Cholesterol and Cholesterol Esters

Slide 1 · Cholesterol and

cholesterol esters

Intracellular accumulation • morphologic recognition • disease correlations

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning goals

Explain how normal cells regulate cholesterol synthesis, uptake, esterification, and trafficking.

Recognize foam cells, lipid vacuoles, and extracellular cholesterol clefts.

Connect deposits with atherosclerosis, xanthomas, cholesterolosis, and Niemann–Pick disease type C.

Use tissue location and molecular mechanism to build a pathologic differential.

Slide 3 · Intracellular accumulation is a metabolic lesion

Normal molecules may accumulate when uptake, synthesis, handling, or removal becomes imbalanced.

Deposits can be innocuous or can disturb organelle function and provoke tissue injury.

Material may be in the cytosol, lysosomes, or other cell compartments.

Accumulation is an observation; The mechanism must be inferred from content and location.

Slide 4 · Four broad routes to intracellular deposits

Impaired handling

Normal material is not effectively removed or transported.

Endogenous abnormal product

Defective folding, transport, or secretion causes retention.

Blocked degradation

Enzyme deficiency prevents normal metabolic clearance.

Indigestible material

External particles are retained because disposal mechanisms are absent.

Slide 5 · Lipids are not one histologic category

Triglycerides

Steatosis: Classically liver parenchymal cells.

Cholesterol / esters

Foam cells in several vascular and extravascular lesions.

Phospholipids

Myelin figures may occur during cell injury and necrosis.

Slide 6 · Cells require cholesterol without storing excess

Cholesterol is a normal constituent needed for cell-membrane synthesis.

Most cells regulate its availability and prevent visible intracellular accumulation.

Prominent vacuolation therefore signals an altered balance or trafficking defect.

The physiological need is not the same as a pathologic excess.

Slide 7 · Free cholesterol versus cholesterol esters

Free cholesterol

Used for membrane synthesis and regulates cellular cholesterol homeostasis.

Cholesteryl esters

Esterified storage form produced when intracellular cholesterol is abundant.

Slide 8 · Cholesterol homeostasis is a flux problem

Lipoprotein uptake

Lysosomal processing

Free cholesterol pool

Utilization or esterification

Feedback also reduces synthesis and receptor-mediated influx when cholesterol rises.

Slide 9 · LDL receptors initiate a regulated uptake pathway

Circulating LDL

LDL receptor binding

Clathrin-coated pit

Internalized vesicle

High-affinity LDL receptors operate in many cell types; Hepatic clearance is prominent.

Slide 10 · Lysosomes release free cholesterol from LDL

Endocytosed LDL

Lysosomal degradation

Cholesteryl ester hydrolysis

Free cholesterol

The apoprotein component is degraded, and esterified cholesterol is converted to free cholesterol.

Slide 11 · NPC1 and NPC2 permit lysosomal egress

Free cholesterol in lysosome

NPC2 + NPC1 transport

Delivery to cellular cholesterol pool

NPC2 is soluble; NPC1 is membrane-associated. A transport defect results in lysosomal retention.

Slide 12 · Intracellular cholesterol restrains synthesis

Higher free cholesterol

Reduced HMG-CoA reductase activity

Lower de novo cholesterol synthesis

A homeostatic negative-feedback response to excess available cholesterol.

Slide 13 · Excess cholesterol is directed to esterification

Higher free cholesterol

Activation of ACAT

Cholesteryl ester storage

ACAT = acyl-coenzyme A:cholesterol acyltransferase.

Slide 14 · Cholesterol suppresses LDL receptor production

Higher free cholesterol

Reduced LDL receptor synthesis

Reduced LDL uptake

Limiting entry is another protection against excessive intracellular cholesterol.

Slide 15 · PCSK9 also modulates receptor recycling

Higher free cholesterol

Increased PCSK9 expression

Greater LDL receptor degradation

Reduced LDL uptake

PCSK9 binding promotes loss of endocytosed receptors rather than their recycling.

Slide 16 · Four safeguards act on cholesterol balance

Synthesis

Feedback reduces HMG-CoA reductase activity.

Storage

ACAT converts excess free cholesterol to esters.

Entry

LDL receptor synthesis is reduced.

Recycling

PCSK9 promotes LDL receptor degradation.

Slide 17 · Why normal regulation can be overwhelmed

Excess input, altered intracellular processing, or impaired egress can exceed compensatory control.

The same lipid can therefore accumulate in different cells by different routes.

Disease identification needs anatomy and cell lineage—not lipid appearance alone.

Synthesis across these textbook sections.

Slide 18 · Cholesterol accumulation has recognizable settings

Atheroma

Intimal macrophages and smooth muscle cells in large arteries.

Xanthoma

Foamy macrophage clusters in skin or tendons.

Cholesterolosis

Foam cells in gallbladder lamina propria.

Niemann–Pick C

Defective lysosomal export; Multiple organs affected.

Slide 19 · A foam cell is a morphology, not a diagnosis

Lipid-rich cytoplasmic spaces

Displaced nucleus

Schematic — not a histologic specimen

Slide 20 · Cytoplasmic vacuoles require interpretation

A clear-appearing cytoplasmic space alone does not identify its chemical content.

In this textbook setting, cholesterol and cholesteryl ester accumulation is associated with foamy vacuolated cells.

Tissue site, architecture, accompanying inflammation, and clinical context refine the diagnosis.

Morphologic interpretation—not a claim that a single routine stain is diagnostic for cholesterol.

Slide 21 · Extracellular cholesterol may leave clefts

Needle-shaped empty clefts after crystal dissolution

Schematic — crystals may be removed by routine tissue processing

Slide 22 · Intracellular lipid and extracellular clefts differ

Intracellular

Pale vacuoles occupy foam-cell cytoplasm.

Extracellular

Released lipids may crystallize; Dissolution during processing leaves needle-like clefts.

Slide 23 · Where are the foam cells located?

Tissue site

Cellular location

Likely teaching context

Artery

Intimal macrophages / SMCs

Atherosclerosis

Skin or tendon

Subepithelial / tendinous macrophages

Xanthoma

Gallbladder

Lamina propria macrophages

Cholesterolosis

Multiple organs

Lysosomal cholesterol accumulation

Niemann–Pick C

Slide 24 · The artery is a major setting for cholesterol storage

Arterial lumen

Fibrous cap

Lipid-rich core

Slide 25 · Atheromas arise within the arterial intima

Large arteries and the aorta develop intimal accumulations of lipid-laden macrophages and smooth muscle cells.

Aggregates form grossly yellow, cholesterol-rich plaques.

Intimal localization is central to recognizing atheromatous disease.

Slide 26 · Hypercholesterolemia promotes intimal lipid entry

Circulating LDL excess

Lipoprotein retention in intima

Modification / oxidation

Cellular lipid uptake

Modified lipoproteins are especially important in building macrophage and smooth muscle foam cells.

Slide 27 · Modified LDL differs from ordinary receptor uptake

Physiologic LDL transport

LDL receptors internalize particles; Feedback limits further influx.

Intimal modified LDL

Scavenger-related uptake by lesional cells contributes to persistent lipid loading.

Slide 28 · Macrophages become foam cells

Intimal modified lipoproteins

Macrophage uptake

Cytoplasmic lipid vacuoles

Foam-cell accumulation

Chronic modified-lipoprotein ingestion produces the characteristic foamy phenotype.

Slide 29 · Smooth muscle cells can also become foam cells

Intimal smooth muscle cell

Uptake of modified lipids

Lipid-laden SMC

Contribution to plaque

Do not equate every plaque foam cell with macrophage lineage.

Slide 30 · Fatty streaks contain foamy macrophages

Early lesions consist mainly of lipid-laden macrophages.

Grossly they are yellow macules or linear streaks.

They generally cause little or no disturbance of blood flow at this stage.

Slide 31 · Fatty streak is not synonymous with mature plaque

Fatty streak

Predominantly foamy macrophages; Limited luminal effect.

Atheromatous plaque

Fibrous cap, cellular elements, extracellular matrix, and lipid-rich necrotic core.

Slide 32 · A mature atheroma contains four component classes

Cells

Macrophages, smooth muscle cells, T lymphocytes.

Extracellular matrix

Collagen, proteoglycans, elastic fibers.

Lipids

Intracellular and extracellular cholesterol-rich material.

Mineral

Calcification may appear in advanced plaques.

Slide 33 · The fibrous cap overlies the lipid-rich core

Arterial lumen

Fibrous cap

Lipid-rich core

Slide 34 · Foam-cell death enlarges the necrotic core

Lipid-laden cells

Cell injury / death

Release of lipid and debris

Necrotic plaque center

This provides a route from cellular storage to extracellular atheromatous material.

Slide 35 · Cholesterol crystals can amplify inflammation

Extracellular cholesterol crystals

Uptake by macrophages

Inflammasome activation

Proinflammatory signaling

Crystal sensing with IL-1–associated local inflammation.

Slide 36 · Inflammation reinforces lipid accumulation

Crystal-driven inflammation

Recruitment of monocytes

More activated foam cells

Additional lipid injury

Atherogenesis is a sustained inflammatory response, not passive lipid deposition.

Slide 37 · Fibrous matrix and inflammatory injury oppose

Matrix deposition

SMCs synthesize collagen and matrix; Cap may be stabilized.

Matrix breakdown

Inflammatory cell products can weaken cap and increase rupture susceptibility.

Slide 38 · Plaque progression can narrow the lumen

Unobstructed lumen

Plaque encroaches on lumen

Slide 39 · Advanced plaques have several complications

Thrombosis

Surface rupture or erosion can expose thrombogenic material.

Intraplaque bleeding

May abruptly increase plaque volume.

Atheroembolism

Dislodged plaque debris can enter distal circulation.

Wall weakening

Medial injury can favor aneurysmal dilation.

Slide 40 · Cholesterol clefts may identify atheromatous debris

Large crystal spaces in plaque cores reflect processing loss of cholesterol crystals.

Clefts can persist among necrotic debris even when many viable foam cells have disappeared.

Distribution in the arterial intima anchors the interpretation as atheromatous.

Slide 41 · Clinical damage is downstream of the plaque lesion

Cholesterol-rich intimal plaque

Stenosis or disruption

Ischemia / thrombosis / embolism

Organ injury

Clinical outcomes depend on vascular distribution and plaque complications.

Slide 42 · Xanthoma is a tissue mass of lipid-laden cells

Aggregates of macrophages acquire conspicuous cholesterol-rich cytoplasmic vacuoles.

Clusters form nodular or tumorous deposits in skin or tendons.

The lesion is a sign of lipid accumulation, not evidence of neoplastic macrophage proliferation.

Slide 43 · Skin and tendons are classic xanthoma sites

Surface epithelium

Subepithelial connective tissue / tendon

Schematic distribution of lipid-laden macrophages

Slide 44 · Xanthomas can accompany different lipid disorders

The chapter associates xanthomas with both hereditary and acquired hyperlipidemic states.

Clinical evaluation should distinguish tissue deposition from the underlying circulating lipoprotein abnormality.

A localized histologic pattern does not itself define which lipoprotein defect is present.

Slide 45 · Familial hypercholesterolemia links LDL and tendons

Reduced functional LDL clearance

Elevated circulating LDL

Cholesterol deposition

Tendon xanthoma + arterial risk

The source links defective hepatic LDL uptake with tendon deposits and accelerated atherosclerosis.

Slide 46 · Xanthoma and atheroma share cells, not anatomy

Xanthoma

Subepithelial connective tissue or tendon; Localized foamy macrophage mass.

Atheroma

Arterial intima; Foamy cells plus matrix, necrotic core, and potential luminal complications.

Slide 47 · Cholesterolosis has a distinct tissue location

Cholesterol-laden macrophages accumulate focally in the gallbladder lamina propria.

The mucosal compartment—not the arterial intima or tendon—is the diagnostic context.

The mechanism of accumulation is unknown.

Slide 48 · Recognize lamina propria foamy macrophages

Gallbladder mucosal epithelium

Lamina propria

Slide 49 · Unknown pathogenesis must remain unknown

Established observation

Focal cholesterol-laden macrophages in gallbladder lamina propria.

Not established in this source

A specific causal route explaining why macrophages accumulate cholesterol here.

Slide 50 · Location discriminates two foamy processes

Feature

Cholesterolosis

Atherosclerosis

Compartment

Gallbladder lamina propria

Arterial intima

Cell emphasis

Cholesterol-laden macrophages

Macrophages and SMCs

Characteristic structure

Mucosal focal accumulations

Atheromatous plaque

Mechanism in Ch. 2

Unknown

Lipid uptake, crystal injury

Slide 51 · Niemann–Pick C is an inherited trafficking defect

This lysosomal storage disease results from pathogenic variants in NPC1 or NPC2.

The primary lesion is failure of nonenzymatic cholesterol transport out of lysosomes.

Cholesterol consequently accumulates across multiple organs.

The short Chapter 2 description says “enzyme”; Chapter 5 clarifies that NPC1/2 are transport proteins, not a hydrolase deficiency.

Slide 52 · NPC1 and NPC2 have complementary locations

NPC1

Membrane-associated protein involved in lysosomal cholesterol export.

NPC2

Soluble lysosomal protein participating in free cholesterol transport.

Slide 53 · Failed export causes lysosomal retention

Lysosomal lumen

NPC2

(soluble)

NPC1

Lysosomal membrane

Cytoplasmic

Cholesterol pool

Blocked export in NPC

Schematic of transport failure: Cholesterol remains within lysosomes

Slide 54 · NPC differs from enzyme-deficiency storage disease

NPC type C

Defective intracellular trafficking of free cholesterol.

Niemann–Pick types A/B

Deficient acid sphingomyelinase with sphingomyelin accumulation.

Slide 55 · NPC affects visceral and neural systems

Marked clinical heterogeneity, including fetal and neonatal presentations.

The more usual chronic form involves progressive neurologic deterioration.

A cellular cholesterol-trafficking disorder can therefore present as a multisystem disease.

Slide 56 · Neurologic clues to NPC type C

Ataxia

Loss of coordinated movement.

Vertical gaze palsy

Supranuclear limitation of vertical eye movements.

Dystonia / dysarthria

Abnormal muscle tone and impaired articulation.

Psychomotor regression

Loss of previously acquired abilities.

Slide 57 · Inherited NPC and acquired deposits should separate

Dimension

Niemann–Pick C

Atheroma / xanthoma

Primary abnormality

NPC1/2 cholesterol transport

Lipid loading in local tissue

Subcellular emphasis

Lysosomal retention

Foam-cell lipid storage

Tissue distribution

Multiorgan

Artery / skin / tendon

Clinical emphasis

Progressive neurologic disease

Vascular or localized deposits

Slide 58 · A pathology differential begins with location

See foamy vacuolated cells

Identify involved tissue

Map cellular compartment

Integrate clinical context

The same cytologic appearance is shared by multiple cholesterol-associated disorders.

Slide 59 · Interpret a cholesterol-associated lesion systematically

Observation

Interpretation

What it does NOT prove

Foamy macrophages

Intracellular lipid accumulation

A single cause or lipid class

Arterial intimal plaque

Supports atheromatous process

That all foam cells are macrophages

Needle-like clefts

Suggests extracellular crystals

That crystals remain in processed tissue

Multisystem storage

Raises inherited trafficking defect

Specific gene without confirmation

Slide 60 · Case: A yellow lesion in an artery

A raised, yellow-tan intimal arterial lesion contains foamy macrophages, smooth muscle cells, a fibrous cap, and empty needle-like spaces.

Which stored material and process best integrate these findings?

Reasoned interpretation: Cholesterol/cholesteryl ester accumulation in an atheromatous plaque; Released crystals leave clefts.

Slide 61 · Case: Tendon nodules and elevated LDL

Tendon nodules contain aggregates of foamy macrophages. The clinical history suggests a hereditary disorder of LDL clearance.

What lesion is present, and what vascular disease should be considered?

Reasoned interpretation: Tendon xanthomas; Inherited hypercholesterolemia can be linked to accelerated atherosclerosis.

Slide 62 · Case: Vacuolated cells in the gallbladder

A gallbladder specimen shows focal groups of lipid-laden macrophages in the mucosal lamina propria.

What is the morphologic term? Can the pathogenesis be asserted?

Reasoned interpretation: Cholesterolosis; The source explicitly describes its accumulation mechanism as unknown.

Slide 63 · Case: Progressive neurologic decline with storage

A multisystem lipid-storage disorder is associated with ataxia, vertical supranuclear gaze palsy, and psychomotor regression.

What trafficking pathway and genes should be considered?

Reasoned interpretation: Niemann–Pick type C, involving NPC1 or NPC2 and impaired lysosomal free-cholesterol export.

Slide 64 · Compare the four primary disease settings

Entity

Main site

Distinctive clue

Atherosclerosis

Large arterial intima

Foam cells, lipid core, crystal clefts

Xanthoma

Skin / tendon

Mass of foamy macrophages

Cholesterolosis

Gallbladder lamina propria

Focal foamy macrophages

Niemann–Pick C

Multiple organs / lysosomes

NPC1/2 transport failure

Slide 65 · Avoid three common diagnostic shortcuts

“Foam cell” describes cytoplasm; It does not specify tissue, disease, or cell lineage.

“Cholesterol crystal” and “cholesterol cleft” refer to related—but not identical—states.

Niemann–Pick type C is a trafficking disorder; It must not be confused with acid sphingomyelinase deficiency.

Slide 66 · Core concepts to retain

Homeostasis

Cells control uptake, synthesis, storage, and transport.

Morphology

Intracellular foam cells differ from extracellular cholesterol clefts.

Location

Artery, tendon/skin, gallbladder, and lysosome provide diagnostic context.

Mechanism

Cholesterol crystals can provoke inflammation; NPC defects impair export.

Slide 67 · Primary teaching references

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026).

Chapter 2, “Intracellular Accumulations,” pp. 56–58; emphasis on cholesterol and cholesterol esters, p. 57.

Chapter 5, cellular cholesterol metabolism, familial hypercholesterolemia, and Niemann–Pick disease type C.

Chapter 11, atherosclerosis: lipid accumulation, foam cells, inflammasome, and plaque morphology.

All diagrams are native, original schematics—not reproduced textbook micrographs.